ARTICLE | Company News
Celtic Therapeutics Holdings L.P., Resolvyx deal
January 17, 2011 8:00 AM UTC
Celtic exercised an October 2010 option from Resolvyx to receive exclusive, worldwide rights to RX-10045 for all ophthalmic indications. Resolvyx will receive an upfront payment and is eligible for m...